178 related articles for article (PubMed ID: 7916651)
1. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
Pfeffer U; Fecarotta E; Castagnetta L; Vidali G
Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651
[TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
3. Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL
Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075
[TBL] [Abstract][Full Text] [Related]
4. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells.
Pfeffer U; Fecarotta E; Vidali G
Cancer Res; 1995 May; 55(10):2158-65. PubMed ID: 7743517
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
Rice LW; Jazaeri AA; Shupnik MA
Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
[TBL] [Abstract][Full Text] [Related]
7. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells.
Rea D; Parker MG
Cancer Res; 1996 Apr; 56(7):1556-63. PubMed ID: 8603402
[TBL] [Abstract][Full Text] [Related]
8. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue.
Leygue E; Dotzlaw H; Watson PH; Murphy LC
Biochem Biophys Res Commun; 1996 Nov; 228(1):63-8. PubMed ID: 8912636
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
Huang A; Leygue ER; Snell L; Murphy LC; Watson PH
Am J Pathol; 1997 May; 150(5):1827-33. PubMed ID: 9137105
[TBL] [Abstract][Full Text] [Related]
11. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas.
Park W; Choi JJ; Hwang ES; Lee JH
Clin Cancer Res; 1996 Dec; 2(12):2029-35. PubMed ID: 9816163
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of estrogen receptor mRNA copy numbers in breast cancer cell lines and tumors.
Poola I; Williams DM; Koduri S; Ramprakash J; Taylor RE; Hankins WD
Anal Biochem; 1998 May; 258(2):209-15. PubMed ID: 9570831
[TBL] [Abstract][Full Text] [Related]
14. A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma.
van Dijk MA; Floore AN; Kloppenborg KI; van 't Veer LJ
Cancer Res; 1997 Aug; 57(16):3478-85. PubMed ID: 9270016
[TBL] [Abstract][Full Text] [Related]
15. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1.
Ohlsson H; Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1998 Oct; 58(19):4264-8. PubMed ID: 9766649
[TBL] [Abstract][Full Text] [Related]
16. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.
Girault I; Andrieu C; Tozlu S; Spyratos F; Bièche I; Lidereau R
Cancer Lett; 2004 Nov; 215(1):101-12. PubMed ID: 15374639
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma.
Weigel RJ; Crooks DL; Iglehart JD; deConinck EC
Cell Growth Differ; 1995 Jun; 6(6):707-11. PubMed ID: 7669725
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer.
Leygue E; Huang A; Murphy LC; Watson PH
Cancer Res; 1996 Oct; 56(19):4324-7. PubMed ID: 8813116
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
[TBL] [Abstract][Full Text] [Related]
20. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
Chan CM; Dowsett M
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
